Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia; Lewy body disease
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 14 May 2015 Status changed from planning to recruiting as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Status changed from not stated to planning.